GMAT考試的優(yōu)秀作文

時(shí)間:2021-08-17 11:00:46 考試 我要投稿

關(guān)于GMAT考試的優(yōu)秀作文精選

  為了方便廣大考生更好的復(fù)習(xí),綜合整理了備考資料:GMAT優(yōu)秀作文精選,以供各位考生考試復(fù)習(xí)參考,希望對(duì)考生復(fù)習(xí)有所幫助。

關(guān)于GMAT考試的優(yōu)秀作文精選

  This ad recommends non-prescription Acid-Ease over non-prescription Pepticaid for relief of excess stomach acid. The only reason offered is that doctors have written 76 million more prescriptions for the full-strength prescription form of Acid-Ease than for full-strength Pepticaid. While this reason is relevant, and provides some grounds for preferring Acid-Ease over Pepticaid, it is insufficient as it stands because it depends on three unwarranted assumptions.

  The first assumption is that the prescription form of Acid-Ease is more popular among doctors. But this might not be the case, even though doctors have written 76 million more prescriptions for Acid-Ease. Acid-Ease may have been available for several more years than Pepticaid; and in the years when both products were available, Pepticaid might have actually been prescribed more often than Acid-Ease.

  The second assumption is that doctors prefer the prescription form of Acid-Ease for the reason that it is in fact more effective at relieving excess stomach acid. However, doctors may have preferred Acid-Ease for reasons other than its effectiveness. Perhaps Acid-Ease is produced by a larger, more familiar drug company or by one that distributes more free samples. For that matter, the medical community may have simply been mistaken in thinking that Acid-Ease was more effective. In short, the number of prescriptions by itself is not conclusive as to whether one product is actually better than another.

【GMAT考試的優(yōu)秀作文】相關(guān)文章:

GMAT考試優(yōu)秀作文10-04

淺析GMAT考試:為GMAT作文01-30

GMAT作文考試范文10-25

GMAT考試參考作文08-07

GMAT作文考試佳句精選08-06

GMAT考試寫作參考作文11-12

gmat作文考試范文:Argument02-09

GMAT考試高分作文07-31

GMAT優(yōu)秀作文欣賞10-06

久久综合国产中文字幕,久久免费视频国产版原创视频,欧美日韩亚洲国内综合网香蕉,久久久久久久久久国产精品免费
亚洲国产精品久久久久秋霞1 | 日韩在线欧美精品一区二区 | 亚洲国产精品va在线观看香蕉 | 亚洲久高清视频在线播放 | 日本最新免费的一区二区 | 午夜福利国产片3 |